Literature DB >> 11238201

Up-regulation of CD40 ligand and induction of a Th2 response in children immunized with pneumococcal polysaccharide vaccines.

L E Leiva1, B Butler, J Hempe, A P Ortigas, R U Sorensen.   

Abstract

We wished to determine whether pneumococcal polysaccharide antigens induce mRNA expression of CD40 ligand (CD40L) and Th1 or Th2 cytokines in unimmunized individuals in vitro and whether immunization with the 23-valent pneumococcal polysaccharide vaccine induces changes in CD40L and cytokine mRNA expression. Children with recurrent respiratory infections were studied before and 4 to 6 weeks after receiving the pneumococcal vaccine. One patient who failed to respond to the polysaccharide vaccine subsequently received a single dose of the experimental 7-valent pneumococcal conjugate vaccine. Unimmunized healthy adults were included as controls. Quantification of mRNA expression of CD40L, interleukin-4 (IL-4), IL-12p40, and gamma interferon (IFN-gamma) was performed by reverse transcription-PCR and enzyme-linked immunosorbent assay (ELISA)-PCR with resting and stimulated peripheral blood mononuclear cells. Serum immunoglobulin G (IgG) anti pneumococcal antibody levels were measured by ELISA. The results showed a significant increase in the expression of mRNAs for CD40L and IL-4, but not IL-12p40 or IFN-gamma, in stimulated cultures from unimmunized individuals. CD40L and IL-4 mRNA expression was significantly higher in postimmunization than in preimmunization samples stimulated with the individual pneumococcal serotypes. These results suggest that pneumococcal polysaccharide antigens specifically up-regulate CD40L expression and induce a Th2 response in vitro which parallels the increase in IgG antipneumococcal antibody levels in serum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238201      PMCID: PMC96042          DOI: 10.1128/CDLI.8.2.233-240.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  35 in total

1.  The CD40 ligand expressed by human B cells costimulates B cell responses.

Authors:  A C Grammer; M C Bergman; Y Miura; K Fujita; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

2.  The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.

Authors:  Y Nishioka; P E Lipsky
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

3.  An in vitro model for T cell-independent induction of humoral immunity. A requirement for NK cells.

Authors:  C M Snapper; H Yamaguchi; M A Moorman; J J Mond
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

Review 4.  T cell-independent antigens type 2.

Authors:  J J Mond; A Lees; C M Snapper
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

5.  The role of NK cells during in vivo antigen-specific antibody responses.

Authors:  J A Wilder; C Y Koh; D Yuan
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

Review 6.  T cell independent antigens.

Authors:  J J Mond; Q Vos; A Lees; C M Snapper
Journal:  Curr Opin Immunol       Date:  1995-06       Impact factor: 7.486

Review 7.  Immunology in the pediatrician's office.

Authors:  R U Sorensen; C Moore
Journal:  Pediatr Clin North Am       Date:  1994-08       Impact factor: 3.278

Review 8.  Lymphokine production by human T cells in disease states.

Authors:  S Romagnani
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies.

Authors:  D H Sniadack; B Schwartz; H Lipman; J Bogaerts; J C Butler; R Dagan; G Echaniz-Aviles; N Lloyd-Evans; A Fenoll; N I Girgis
Journal:  Pediatr Infect Dis J       Date:  1995-06       Impact factor: 2.129

Review 10.  The role of CD40 in the regulation of humoral and cell-mediated immunity.

Authors:  F H Durie; T M Foy; S R Masters; J D Laman; R J Noelle
Journal:  Immunol Today       Date:  1994-09
View more
  7 in total

Review 1.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

2.  Chronic Chlamydia pneumoniae infection may promote coronary artery disease in humans through enhancing secretion of interleukin-4.

Authors:  R Clancy; Z Ren; G Pang; P Fletcher; C D'Este
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

3.  Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan.

Authors:  Laura S Chiapello; José L Baronetti; María P Aoki; Susana Gea; Héctor Rubinstein; Diana T Masih
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

Review 4.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

5.  A Critical View of Specific Antibody Deficiencies.

Authors:  Ricardo U Sorensen
Journal:  Front Immunol       Date:  2019-05-01       Impact factor: 7.561

6.  Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to Streptococcus pneumoniae Type 3 Capsular Polysaccharide.

Authors:  Ekaterina A Kurbatova; Nelli K Akhmatova; Anton E Zaytsev; Elina A Akhmatova; Nadezhda B Egorova; Natalya E Yastrebova; Elena V Sukhova; Dmitriy V Yashunsky; Yury E Tsvetkov; Nikolay E Nifantiev
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

7.  HIV-Infected Spleens Present Altered Follicular Helper T Cell (Tfh) Subsets and Skewed B Cell Maturation.

Authors:  Lucie Colineau; Angeline Rouers; Takuya Yamamoto; Yin Xu; Alejandra Urrutia; Hang-Phuong Pham; Sylvain Cardinaud; Assia Samri; Karim Dorgham; Pierre-Grégoire Coulon; Rémi Cheynier; Anne Hosmalin; Eric Oksenhendler; Adrien Six; Anthony D Kelleher; John Zaunders; Richard A Koup; Brigitte Autran; Arnaud Moris; Stéphanie Graff-Dubois
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.